Morningstar International Shares Active ETF (Managed Fund)

MSTR

MSTR.AX was created on 2013-07-01 by Morningstar. The fund's investment portfolio concentrates primarily on total market equity. To achieve meaningful capital growth over the medium-to-long term, while minimising the risk of permanent capital loss, by providing exposure to listed international shares

Mitchell Services Limited

MSV

Mitchell Services Ltd. engages in the provision of drilling services to the mining industry. The company is headquartered in Brisbane, Queensland. The company went IPO on 2011-08-02. The firm is engaged in providing exploration and mine site drilling services to the exploration and mining industries within Australia. The firm provides drilling solutions at all stages of the mining lifecycle, in both the energy and minerals sectors. Its various stages of the mining lifecycle for which the Company provides drilling services, including greenfield exploration, project feasibility, mine site exploration and resource definition, development, and production. Its geographical areas include Queensland, New South Wales, Tasmania, Western Australia, Victoria and Northern Territory. The Company’s wholly owned subsidiaries include Notch Holdings Pty Ltd, Notch No. 2 Pty Ltd, Mitchell Services Share Plan Pty Ltd and Radco Group Australia Pty Ltd.

Mesoblast Limited

MSB

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. The company is headquartered in Melbourne, Victoria and currently employs 73 full-time employees. The company went IPO on 2004-12-16. The company has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. The company is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. The company has established commercial partnerships in Europe and China for certain Phase III assets.

Mcs Services Limited

MSG

MCS Services Ltd. engages in the provision of retail and event security. The firm's segments include Security and Traffic. The company provides uniformed unarmed guards to shopping centers, sporting events, entertainment events, hospitals, government building, corporate offices and community facilities, together with covert security, alarm installation and closed-circuit television (CCTV) monitoring, primarily in Western Australia. The company offers services, including retail security, loss prevention, event security, educational security, marine security, industrial security, healthcare security and integrated systems. Its subsidiaries include MCS Security Group Pty Ltd, which offers security services at commercial property sites and retail shopping centers throughout the Perth metropolitan area and regional country areas of Western Australia, and Highways Traffic Pty Ltd, which offers traffic management services primarily to highway construction projects in Western Australia.